WT1 and Kaposi's sarcoma: Analyses of pretreatment KS biopsy specimens from this study indicated high expression of WT-1 (Wilms tumor protein) in KS lesions, identifying a potential future therapeutic target in KS,22 as well as an association between large numbers of CD8+ cells in KS lesions and KSHV gene expression.23